692 related articles for article (PubMed ID: 23526388)
21. Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.
Benevento M; Munoz J
Expert Rev Proteomics; 2012 Aug; 9(4):379-99. PubMed ID: 22967076
[TBL] [Abstract][Full Text] [Related]
22. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
Cebrian-Serrano A; Stout T; Dinnyes A
Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
[TBL] [Abstract][Full Text] [Related]
23. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
24. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
[TBL] [Abstract][Full Text] [Related]
25. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?
Ronaghi M; Erceg S; Moreno-Manzano V; Stojkovic M
Stem Cells; 2010 Jan; 28(1):93-9. PubMed ID: 19904738
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cells in medicine and biology.
Takahashi K; Yamanaka S
Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
[TBL] [Abstract][Full Text] [Related]
27. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
28. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
Kanawaty A; Henderson J
Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
[TBL] [Abstract][Full Text] [Related]
29. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming.
Vaziri H; Chapman KB; Guigova A; Teichroeb J; Lacher MD; Sternberg H; Singec I; Briggs L; Wheeler J; Sampathkumar J; Gonzalez R; Larocca D; Murai J; Snyder E; Andrews WH; Funk WD; West MD
Regen Med; 2010 May; 5(3):345-63. PubMed ID: 20230312
[TBL] [Abstract][Full Text] [Related]
31. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
Yamakawa H; Ieda M
Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
[TBL] [Abstract][Full Text] [Related]
32. Embryonic stem cells from blastomeres maintaining embryo viability.
Klimanskaya I
Semin Reprod Med; 2013 Jan; 31(1):49-55. PubMed ID: 23329636
[TBL] [Abstract][Full Text] [Related]
33. Genomic stability in reprogramming.
Ronen D; Benvenisty N
Curr Opin Genet Dev; 2012 Oct; 22(5):444-9. PubMed ID: 23040504
[TBL] [Abstract][Full Text] [Related]
34. Reprogramming to iPS cells and their subsequent hematopoietic differentiation is more efficient from MEFs than from preB cells.
Reimer A; Seiler K; Tornack J; Tsuneto M; Melchers F
Immunol Lett; 2012 Mar; 143(1):70-6. PubMed ID: 22313949
[TBL] [Abstract][Full Text] [Related]
35. [From Gurdon to Yamanaka--a brief history of cell reprogramming].
Kubiak JZ; Ciemerych MA
Postepy Biochem; 2013; 59(2):124-30. PubMed ID: 24044277
[TBL] [Abstract][Full Text] [Related]
36. An introduction to induced pluripotent stem cells.
Hanley J; Rastegarlari G; Nathwani AC
Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
[TBL] [Abstract][Full Text] [Related]
37. Embryonic stem cell extracts: use in differentiation and reprogramming.
Han J; Sidhu K
Regen Med; 2011 Mar; 6(2):215-27. PubMed ID: 21391855
[TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.
Lee H; Park J; Forget BG; Gaines P
Regen Med; 2009 Sep; 4(5):759-69. PubMed ID: 19761400
[TBL] [Abstract][Full Text] [Related]
39. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
40. Reproductive medicine gets a new tool.
Ang WX; Toh CX; Ng HH; Loh YH
J Mol Cell Biol; 2011 Dec; 3(6):320-1. PubMed ID: 22116889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]